Skip to main content
. 2019 Feb 7;5(4):523ā€“528. doi: 10.1001/jamaoncol.2018.6760

Table. Most Frequently Detected Variants in Patients With a Personal History of Prostate Cancer.

Gene No. of Requisitions Variants of Uncertain Significance Detected Positive Variants Detected, nā€‰=ā€‰674, (%) Positive Variants per Requisition, %a
BRCA2 3459 75 164 (24.3) 4.74
CHEK2 3300 71 95 (14.1) 2.88
ATM 3207 160 65 (9.6) 2.03
MUTYH 2322 27 55 (8.2) 2.37
BRCA1 3436 38 43 (6.4) 1.25
HOXB13 2667 0 30 (4.5) 1.12
APC 2345 76 30 (4.5) 1.28
MSH2 3350 48 23 (3.4) 0.69
TP53 3329 30 22 (3.3) 0.66
PALB2 3014 42 17 (2.5) 0.56
PMS2 3345 50 18 (2.7) 0.54
MSH6 3346 75 15 (2.2) 0.45
NBN 3145 41 10 (1.5) 0.32
RAD50 2173 40 7 (1.0) 0.32
BRIP1 2461 36 7 (1.0) 0.28
RAD51C 2438 21 5 (0.7) 0.21
RAD51D 2689 12 4 (0.6) 0.15
CDKN2A 2277 6 3 (0.4) 0.13
CDH1 2504 28 3 (0.4) 0.12
NF1 2347 35 2 (0.3) 0.09
MLH1 3343 25 2 (0.3) 0.06
a

Percentages of positive variants per total gene requisitions are calculated as the number of positive variants in a gene divided by the total number of requisitions for that gene.